Elsevier, Alzheimer's Disease and Advanced Drug Delivery Strategies, Volume , 1 January 2023
The most prevalent type of neurogenerative condition linked to dementia, based on the current situation, is Alzheimer's Disease (AD).
Elsevier, Side Effects of Drugs Annual, Volume 45, January 2023
Medications used in the treatment of Alzheimer's disease include the acetylcholinesterase inhibitors (AChEIs, i.e., donepezil, rivastigmine, and galantamine), the N-methyl-D-aspartate receptor (NDMAR) antagonist, memantine, and the anti-amyloid beta monoclonal antibody, aducanumab.
Elsevier, Diet and Nutrition in Neurological Disorders, Volume , 1 January 2023
This chapter discusses any plausible correlation between malnutrition and the onset of Alzheimer's disease. An overview of Alzheimer's pathophysiology is included to offer an understanding of the various underlying causes leading to its manifestation.
Diagram of Esophageal Atresia & Tracheoesophageal Fistula
This article ties to SDG 3. This resource, created together by Osmosis and the National Organization for Rare Diseases (NORD), aims to increase the knowledge and awareness about the rare birth defect Esophageal Atresia & Tracheoesophageal Fistula. This disease occurs when the esophagus fails to develop correctly, essentially ending in a blind pouch that is commonly connected to the trachea, creating a tracheoesophageal fistula.
This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by identifying barriers for individuals with ID, their impact on long-term outcomes, and strategies that academics can use to foster positive identity development for this population.
This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by exploring how experiential knowledge can complement professional and scientific knowledge and underscoring the benefits of incorporating experiential knowledge within the development of evidence-based care and support for people with intellectual disabilities.
This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by reviewing the current therapies for neurological disorders and their limitations.
Elsevier,

The Youth Athlete: A Practitioner's Guide to Providing Comprehensive Sports Medicine Care, Volume , 1 January 2023

This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by treating access and inclusion as human rights issue and highlighting information to providers about caring for athletes with physical disabilities.
Elsevier,

The Youth Athlete: A Practitioner's Guide to Providing Comprehensive Sports Medicine Care, Volume , 1 January 2023

This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by providing a comprehensive review of specific considerations for the promotion of sports participation in youth athletes with intellectual disabilities.
This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by summarizing the commonly used instruments for the assessment of patient’s pain, quality of life, physical limitations, and psychological impact.

Pages